Iris Holt-Kedde

Ms. Iris Holt-Kedde

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MZMieke Zwager
Mieke Zwager
IHIris Holt-Kedde
Iris Holt-Kedde
HTHetty Timmer-Bosscha
Hetty Timmer-Bosscha
GBGeertruida de Bock
Geertruida de Bock
PWPaul M. N. Werker
Paul M. N. Werker
MAMarlous Arjaans
Marlous Arjaans

5 October 2025 in JPRAS Open
Verified
Journal Article
Open access
LTLauren L. van Tits
Lauren L. van Tits
OMOlga F. Marin
Olga F. Marin
IHIris Holt-Kedde
Iris Holt-Kedde
VAVera C. van Aalst
Vera C. van Aalst
MVMartinus M. van Veen
Martinus M. van Veen
The Goldilocks mastectomy was originally developed as a “middle ground” between a breast reconstruction and a modified radical mastectomy, particularly for obese women who are poor candidates for direct breast reconstruction. This scoping review aims to provide an overview of surgical techniques, complications, cosmetic outcomes and patient-reported quality of life following the Goldilocks mastectomy. Following the PRISMA-ScR guidelines a systematic search was conducted in March 2025, using PubMed and Embase. The identified studies were screened by two independent reviewers, based on predefined inclusion and exclusion criteria. Data focusing on surgical technique, complications and outcomes was extracted and recorded. Fourteen articles were included, representing a total of 486 women (758 breasts). The majority were retrospective cohort studies. The Goldilocks mastectomy techniques reported varied, with some studies describing modifications to add more volume or cause less scarring. Common complications included seroma, wound dehiscence and fat necrosis. Four studies reported on secondary surgeries for volume enhancement. Three studies assessed cosmetic outcomes, which showed mixed results. Patient-reported quality of life, measured using the BREAST-Q, showed scores comparable to traditional reconstruction techniques. Goldilocks mastectomy provides a safe reconstructive option, especially for obese patients. Complication rates are comparable to those found in traditional mastectomy techniques and patient satisfaction appears favorable. However, limited high-quality evidence exists regarding long-term cosmetic outcomes and quality of life measurements. Further research using more standardized outcome measures is needed to fully evaluate the pros and cons of the Goldilocks mastectomy in breast reconstruction.

27 January 2025 in Breast Care
Verified
Journal Article
Open access
IHIris Holt-Kedde
Iris Holt-Kedde
NSNadia Sadok
Nadia Sadok
IKIrene S. Krabbe-Timmerman
Irene S. Krabbe-Timmerman
GBGeertruida H. de Bock
Geertruida H. de Bock
GSGrigory Sidorenkov
Grigory Sidorenkov
PWPaul M.N. Werker
Paul M.N. Werker
Objective: Quality of life (QoL) following autologous breast reconstruction has been found to be higher compared to alloplastic breast reconstruction. However, evaluating QoL is complex as it is influenced by various factors, including patient characteristics and treatment types. Previous studies comparing QoL between reconstruction techniques have not sufficiently addressed baseline differences between patient groups, some of which contribute to indication bias. Using an alternative approach to identify the confounders, this study aimed to evaluate which factors affect the patient satisfaction and QoL after alloplastic or autologous reconstruction, with follow-up extending up to 3 years post-surgery. Method: QoL and satisfaction were measured using the Breast-Q preoperatively and after breast reconstruction (post-BR) at 6 weeks, 6 months, 1 year, and 3 years. General and mental health were measured using the SF-36 and the HADS. A generalized linear mixed model was utilized to assess which factors confound the relationship between reconstruction technique and Breast-Q scores. Results: Factors contributing to the disparity in Breast-Q scores between autologous and alloplastic breast reconstruction varied across Breast-Q subscales. Autologous breast reconstruction patients consistently reported higher “Satisfaction with Breasts” and “Physical Well-being,” while the minimal important differences in “Psychosocial” and “Sexual Well-being” were lost after adjustment for confounding factors. Conclusion: This study confirms that even when adjusted for confounders, scores on two QoL subscales autologous breast reconstruction patients score significantly higher over time. Although autologous reconstruction remained superior regarding “Satisfaction with Breasts,” scores decreased in autologous reconstruction patients when they were depressed at baseline, underwent radiotherapy, had a history of breast cancer, or faced major complications.

8 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
IHIris Holt-Kedde
Iris Holt-Kedde
HTHetty Timmer-Bosscha
Hetty Timmer-Bosscha
Frank A. E. KruytFrank A. E. Kruyt
Frank A. E. Kruyt
WKWendy Kelder
Wendy Kelder
BVBert van der Vegt
Bert van der Vegt
MAMarlous Arjaans
Marlous Arjaans
Background: Obesity is a recognized risk factor for developing breast cancer (BC), but factors involved remain unclear. We investigated if breast adipose tissue from healthy women, BRCA1/2 mutation carriers and BC patients, can stimulate BC cell line migration and activation. Methods: adipose tissue conditioned medium (ATCM), was prepared from breast adipose tissue from healthy subjects (naïve; group 1 (n = 20)), BRCA1/2 mutation carriers (group 2 (n = 22)) and BC patients (group 3 (n = 38)). ATCM effect on migration of BC cell lines MCF-7, SK-BR-3 and MDA-MB-231 was measured with xCELLigence (ACEA Biosciences, San Diego, CA, USA) cell migration assay. Activation of migration was determined by measuring filopodia activation. Migration and filopodia activation were related to body mass index (BMI) and BC subtypes. Luminex multiplex assay was performed to examine the secretory profile of adipose tissue. Results: ATCM from group 1 induced migration and filopodia activation in MCF-7 and MDA-MB-231, but not in SK-BR-3. ATCM from group 2 induced filopodia activation but no migration. ATCM from group 3 induced less migration in MCF-7 than ATCM from group 1. Higher BMI was associated with increased ATCM-induced activation in MCF-7 (group 1) and MDA-MB-231 (group 2). ATCM from group 1 and 2 showed a metabolic secretory profile, whereas group 3 showed higher pro-angiogenic and inflammatory cytokines. Conclusions: This study shows that breast adipose tissue from healthy women, BRCA1/2 mutation carriers and BC patients, can stimulate BC cell line migration and activation. This effect is related to BC subtype and BMI. These data improve insight in adipose tissue as factor in BC development.


4 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
TMTamar Muntslag
Tamar Muntslag
MVMartinus van Veen
Martinus van Veen
VAVera van Aalst
Vera van Aalst
IHIris Holt-Kedde
Iris Holt-Kedde
The Goldilocks mastectomy was first described as an alternative to mastectomy for obese patients to limit surgical burden, by avoiding the extremes of traditional reconstruction. A frequently mentioned limitation of the technique in non-obese patients is lack of breast volume postoperatively. In these cases however, patient reported satisfaction and outcomes are limited. With this pilot study we aimed to fill the gap in knowledge on satisfaction after Goldilocks mastectomy in non-obese patients using the validated BREAST-Q instrument. Our findings support broader implementation in this patient population, particularly for those patients seeking a simpler, autologous reconstruction.